Chronic Treatment | Control | (−)-Menthol | Nicotine | Nicotine and (−)-Menthol |
---|---|---|---|---|
(−)-Menthol (nM) | 0 | 500 | 0 | 500 |
Nicotine (µM) | 0 | 0 | 250 | 250 |
% Zn2+ inhibitiona (%) | 50.1 ± 6.5 | 48.5 ± 4.8 | 48.7 ± 6.1 | 55.4 ± 5.3 |
N | 14 | 16 | 19 | 20 |
Cell capacitance (pF)a | 28.2 ± 5.3 | 23.3 ± 2.5 | 22.5 ± 1.9 | 22.9 ± 1.9 |
Current density (pA/pF)a,b | −108.4 ± 31.6 | −91.4 ± 15.6 | −62.7 ± 10.4 | −71.9 ± 12.3 |
↵a P > 0.05 for one-way ANOVA with post-hoc Tukey HSD test.
↵b Current density between these same chronic treatments with higher N numbers for control and chronic (−)-menthol treatment are shown in Table 3 and discussed in Results in the section entitled Chronic Nicotine But Not Chronic Menthol Treatment Reduces Functional PM Mouse α3β4 nAChR Levels.